CHAPTER 5 Nervous System^223
- Occipital lobe:
- Impaired vision—defect in visual fields; patient may deny or be unaware
of defect - Prosopagnosia (patient is unable to recognize familiar faces)
 - Change in color perception
 
 - Impaired vision—defect in visual fields; patient may deny or be unaware
 - Parietal lobe:
- Seizures
 - Sight disturbances result in visual field defect
 - Sensory loss—unable to identify object placed in hand without looking
 
 - Temporal lobe:
- Seizures
 - Taste or smell hallucinations
 - Auditory hallucinations
 - Depersonalization
 - Emotional changes
 - Visual field defects
 - Receptive aphasia
 - Altered perception of music
 
 
INTERPRETING TEST RESULTS
- MRI with gadolinium (contrast) defines tumor location, size.
 - CT scan shows characteristic appearance of meningioma.
 - Angiography will show blood flow to the area; some tumors will displace
vessels as they grow. 
TREATMENT
- Chemotherapeutic agents alone or in combination with radiation and surgery.
May be given orally, intravenously or through an Ommaya reservoir. Drugs
are chosen based on cell type:- carmustine, lomustine, procarbazine, vincristine, temozolomide, erlotinib,
gefitinib 
 - carmustine, lomustine, procarbazine, vincristine, temozolomide, erlotinib,